Journal Menu► ▼ Journal Menu
Journal Browser► ▼ Journal Browser
Special Issue "New Insights on Drug Design, Delivery and Targeting in Neurodegeneration"
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Drug Targeting and Design".
Deadline for manuscript submissions: 31 July 2023 | Viewed by 10227
Special Issue Editors
2. UCIBIO - Applied Molecular Biosciences Unit, REQUIMTE, Laboratory of Toxicology, Department of Biological Sciences, Faculty of Pharmacy, University of Porto, 4050-313 Porto, Portugal
Interests: toxicology; pharmacology; ADME/toxicokinetics; membrane transporters; P-glycoprotein; neurodegeneration; drugs of Abuse; drug discovery
2. Cell Division Mechanisms Group, Institute for Research and Innovation in Health (i3S), University of Porto, 4200-135 Porto, Portugal
Interests: molecular motors; intracellular transport; cell biology; molecular biology; drugs of abuse; neurodegeneration; pharmacology; toxicology; forensic sciences
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Neurodegenerative diseases represent a heterogenous group of disorders characterized by progressive degeneration and death of neuronal populations. They affect millions of people worldwide, greatly impacting patient’s quality of life and raising strong economic and health concerns for society. This problem is even more fundamental as the available therapies remain fairly limited and mainly focusing on symptoms relief. Thus, the development of novel drug candidates, based on state-of-the-art chemistry methodologies and/or sparsely explored chemical substances, could help to identify lead compounds with potential pharmaceutical application.
On the other hand, in most cases, the lack of drug efficacy in neurodegeneration treatment comes from a compromised drug delivery to their target sites. Thus, the development of cutting-edge drug delivery systems and approaches would add substantial advance in neurodegeneration treatment.
In this special issue we are interested in reviews and original articles describing novel chemical design-based drug candidates and improved delivery systems to target sites with potential to deal with neurodegeneration.
Prof. Dr. Renata Silva
Prof. Dr. Daniel José Barbosa
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- drug design and discovery
- drug delivery
- drug targeting
- new therapeutic strategies
- in vitro models of neurodegeneration